Lv6
2510 积分 2025-06-13 加入
A phase II study of afatinib in combination with pemetrexed and carboplatin in patients with EGFR mutation-positive non-squamous, advanced non-small cell lung cancer (NSCLC) refractory to first-line osimertinib treatment: NEJ025B Study
3小时前
待确认
Overcoming EGFR mutation resistance: Dual inhibition strategies using TKIs in non-small cell lung cancer therapy
3小时前
已完结
Accurate Selection of Sublobar Resection for Small Non-small Cell Lung Cancer
23天前
已完结
Using 18F-FDG PET/CT-derived body composition features to predict lymphovascular invasion in non-small cell lung cancer
1个月前
已完结
Comparable clinical outcomes between segmentectomy and lobectomy for NSCLC with unsuspected N1/N2: A multicenter real-world data study
2个月前
已完结
Role of Pathologic Single-Nodal and Multiple-Nodal Descriptors in Resected Non-Small Cell Lung Cancer
3个月前
已完结
皖公网安备34019202002308
